Mycophenolic acid inhibits IL-2-dependent T cell proliferation, but not IL-2-dependent survival and sensitization to apoptosis

Journal of Immunology

Volumn 169, Issue 5, 2002, Pages 2747-2755

  Quéméneur, Laurence ^a   Flacher, Monique ^a   Gerland, Luc Marie ^a   Ffrench, Martine ^a   Revillard, Jean Pierre ^a   Bonnefoy Berard, Nathalie ^a  

^a INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN E; CYTOKINE; FAS ANTIGEN; GUANOSINE; INTERLEUKIN 15; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR; INTERLEUKIN 2 RECEPTOR ANTIBODY; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGENIC AGENT; MIZORIBINE; MYCOPHENOLIC ACID; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; NUCLEOTIDE; PROTEIN BCL XL; PROTEIN P27; RAPAMYCIN; STAT5 PROTEIN; T LYMPHOCYTE RECEPTOR;

APOPTOSIS; ARTICLE; CELL ACTIVATION; CELL CYCLE; CELL CYCLE G1 PHASE; CELL PROLIFERATION; CELL SURVIVAL; CONTROLLED STUDY; DOWN REGULATION; HUMAN; HUMAN CELL; LYMPHOBLAST; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SENSITIZATION; SIGNAL TRANSDUCTION; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION;

EID: 0036721788     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.169.5.2747     Document Type: Article

References (47)

1. Mycophenolate mofetil and its mechanisms of action
2. Effects of human T lymphocyte activation on inosine monophosphate dehydrogenase expression
3. Importance of ribonucleotide availability to proliferating T-lymphocytes from healthy humans: Disproportionate expansion of pyrimidine pools and contrasting effects of de novo synthesis inhibitors
4. Characterization of human type I and type II IMP dehydrogenases
5. Biochemical differences among four inosinate dehydrogenase inhibitors, mycophenolic acid, ribavirin, tiazofurin, and selenazofurin, studied in mouse lymphoma cell culture
6. Mycophenolic acid-induced GTP depletion also affects ATP and pyrimidine synthesis in mitogen-stimulated primary human T-lymphocytes
7. Comparison of the effects of mizoribine with those of azathioprine, 6-mercaptopurine, and mycophenolic acid on T lymphocyte proliferation and purine ribonucleotide metabolism
8. Lymphocyteselective cytostatic and immunosuppressive effects of mycophenolic acid in vitro: Role of deoxyguanosine nucleotide depletion
9. Effects of guanine nucleotide depletion on cell cycle progression in human T lymphocytes
10. Mycophenolate mofetil impairs the maturation and function of murine dendritic cells
11. Inactivation of a Cdk2 inhibitor during interleukin 2-induced proliferation of human T lymphocytes
12. O T cells
13. Kip1 cyclin-dependent kinase inhibitor prevented by rapamycin
14. Guanine ribonucleotide depletion inhibits T cell activation: Mechanism of action of the immunosuppressive drug mizoribine
15. Cytokine-induced survival of activated T cells in vitro and in vivo
16. S) gene expression
17. Development and proliferation of lymphocytes in mice deficient for both interleukins-2 and -4
18. Development and function of T cells in mice rendered interleukin-2 deficient by gene targeting
19. Biochemical mechanisms of IL-2-regulated Fas-mediated T cell apoptosis
20. Regulatory CD4 T cells: Expression of IL-2Rα chain, resistance to clonal deletion and IL-2 dependency
21. + T cells: Evidence for two distinct regulatory mechanisms
22. Blocking both signal 1 and signal 2 of T-cell activation prevents apoptosis of alloreactive T cells and induction of peripheral allograft tolerance
23. Interleukin-2 programs mouse αβ T lymphocytes for apoptosis
24. Requirement for T-cell apoptosis in the induction of peripheral transplantation tolerance
25. The interleukin-2 T-cell system: A new cell growth model
26. 1 cyclin-dependent kinases
27. Kip1
28. Kip1 degradation and anchorage independence by Ras through the MAP kinase signaling pathway
29. 1 arrest in exponentially growing T-cell lines
30. Activation of Stat5 by interleukin 2 requires a carboxyl-terminal region of the interleukin 2 receptor β chain but is not essential for the proliferative signal transmission
31. Stat5 is required for IL-2-induced cell cycle progresssion of peripheral T cells
32. Uncoupling IL-2 signals that regulate T cell proliferation, survival, and Fas-mediated activation-induced cell death
33. Three distinct IL-2 signaling pathways mediated by bcl-2, c-myc, and lck cooperate in hematopoietic cell proliferation
34. 1/S transition to acquire susceptibility to Fas-mediated apoptosis
35. Cell cycle-dependent regulation of FLIP levels and susceptibility to Fas-mediated apoptosis
36. 1 prolongation in mitogen-activated T lymphocytes
37. Kip1
38. + T cells
39. Activation interferes with the APO-1 pathway in mature human T cells
40. Inhibition of death receptor signals by cellular FLIP
41. Viral FLICE-inhibitory proteins (FLIPs) prevent apoptosis induced by death receptors
42. CTLA4-Ig and anti-D40 ligand prevent renal allograft rejection in primates
43. Treatment with humanized monoclonal antibody against CD154 prevents acute renal allograft rejection in nonhuman primates
44. Induction of allograft tolerance in the absence of Fas-mediated apoptosis
45. Regulatory T cells in the control of immune pathology
46. + regulatory cells?
47. 3 and mycophenolate mofetil treatment mediate transplantation tolerance